Mednet Member
Neurology · University of Minnesota
No. I discuss riluzole with all patients and explain that it prolongs survival in ALS by a variable amount of time, usually around 3-4 months- therefore, if the patient wants to use anything available to prolong their life, they should take it. I also explain, however, that riluzole will not stop di...
Mednet Member
Neurology · Yale
I do. My personal experience has been that it is well-tolerated and generally not a financial burden. It is often difficult to explain the expected benefit other than that it may slow their course, but given that all courses are different, I'm generally hesitant to give specific expectations (e.g. i...